The year in opioid settlements: 5 things you need to know

This year, about $1.5 billion has landed in state and local government coffers from court settlements made with more than a dozen companies that manufactured, sold, or distributed prescription painkillers and were sued for their role in fueling the opioid crisis.

LEO-152020 by Leo Pharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 28, 2023

Cell therapy startup A2 Biotherapeutics nets $80M Series C

A2 Biotherapeutics has raised $80 million to run three experimental CAR-T programs for solid tumor cancers. The biotech is developing what it calls logic-gated cell

January 10, 2025

Newborn Screening Downgrades Prevalence of SMA

Newborn screening programs have revised prevalence estimates of spinal muscular atrophy (SMA), with data showing fewer cases than expected in the U.S. Based on population-level

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.